This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business collaboration agreement

Eli Lilly and WHO Foundation Collaborate on Obesity

Analysis based on 8 articles · First reported Mar 06, 2026 · Last updated Mar 06, 2026

Sentiment
30
Attention
2
Articles
8
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The collaboration between Eli Lilly and Company and the WHO Foundation is expected to have a positive impact on the healthcare market, particularly in the obesity care sector, by strengthening health systems and promoting early diagnosis and care. This initiative could also enhance the public image and market sentiment for both Eli Lilly and Company and the WHO Foundation.

Pharmaceuticals Healthcare

The WHO Foundation announced a collaboration with Eli Lilly and Company to strengthen health systems for obesity prevention and care globally. Eli Lilly and Company is committing $1.68 million to the WHO Foundation until 2029 to support these efforts. The initiative aims to address obesity as a public health priority, enable access to early diagnosis, counseling, and care, and reduce the worldwide economic impact of obesity. Anil Soni, CEO of the WHO Foundation, and Patrik Jonsson, Executive Vice President and President of Lilly International, highlighted the importance of this collaboration in building robust health systems and slowing the global progression of obesity.

95 WHO Foundation announced collaboration Eli Lilly and Company
90 Eli Lilly and Company committed $1.68 million in funding WHO Foundation
ngo
The WHO Foundation announced a collaboration with Eli Lilly and Company to support global efforts in assessing and strengthening health systems for obesity prevention and care. This collaboration will help the WHO Foundation in its mission to advance health equity and respond to urgent health challenges.
Importance 90 Sentiment 50
stock
Eli Lilly and Company is committing $1.68 million to the WHO Foundation until 2029 to strengthen health systems for obesity care. This collaboration aligns with Eli Lilly and Company's goal to help people living with obesity receive the care they need and slow the global progression of the disease.
Importance 90 Sentiment 40
per
Anil Soni, CEO of the WHO Foundation, highlighted that the collaboration is crucial for building health systems prepared to respond to obesity across the life course, integrating evidence-based policies, and developing training standards.
Importance 60 Sentiment 30
per
Patrik Jonsson, Executive Vice President and President of Lilly International, emphasized that Eli Lilly and Company's collaboration with the WHO Foundation will help countries assess care gaps and strengthen primary health care for obesity prevention and care.
Importance 60 Sentiment 30
alliance
The WHO Foundation was created to support the mission of the World Health Organization, and this collaboration contributes to the broader goals of addressing global health challenges like obesity.
Importance 30 Sentiment 20
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.